Toggle navigation
PDFSEARCH.IO
Document Search Engine - browse more than 18 million documents
Sign up
Sign in
Back to Results
First Page
Meta Content
View Document Preview and Link
REMS Document Initial Approval[removed]NDA[removed] Iclusig® (ponatinib) tablets
Add to Reading List
Open Document
File Size: 1,35 MB
Share Result on Facebook
City
Philadelphia /
Reference /
Cambridge /
/
Company
ARIAD /
Clinical Oncology Blood New England Journal /
Tyrosine Kinase Inhibitor ARIAD Pharmaceuticals Inc. /
Kinase Inhibitor ARIAD Pharmaceuticals /
Inc. /
/
Event
FDA Phase /
Man-Made Disaster /
/
/
MedicalCondition
positive acute lymphoblastic leukemia /
chronic phase /
blast phase /
chronic myeloid leukemia /
thromboembolism /
/
Organization
FDA /
American Society of Health-System Pharmacists /
Hematology Oncology Pharmacy Association /
American Society of Hematology /
American Society of Clinical Oncology /
American Pharmacists Association /
Oncology Nursing Society /
/
/
Product
Iclusig® (ponatinib) tablets /
/
ProvinceOrState
Massachusetts /
/
URL
www.IclusigREMS.com /
/
SocialTag
Ponatinib
Chronic myelogenous leukemia
Rems
Alkynes
Organofluorides
Piperazines